From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 1,873.00
-77.00 (-3.95%)
At close: Oct 8, 2026
From Bio Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 71,639 | 72,162 | 67,182 | 66,724 | 99,330 | 135,103 |
Other Revenue | 0 | - | - | - | -0 | -0 |
| 71,639 | 72,162 | 67,182 | 66,724 | 99,330 | 135,103 | |
Revenue Growth | 8.25% | 7.41% | 0.69% | -32.83% | -26.48% | - |
Cost of Revenue | 26,536 | 30,612 | 30,036 | 20,769 | 30,022 | 32,999 |
Gross Profit | 45,103 | 41,551 | 37,145 | 45,955 | 69,309 | 102,104 |
Selling, General & Admin | 60,252 | 58,945 | 60,199 | 60,432 | 67,684 | 90,018 |
Amortization of Goodwill & Intangibles | 82.01 | 92.11 | 98.03 | 86.33 | 221.76 | 112.89 |
Operating Expenses | 61,383 | 60,152 | 61,416 | 61,375 | 68,412 | 90,680 |
Operating Income | -16,280 | -18,601 | -24,271 | -15,420 | 897.02 | 11,424 |
Interest Expense | -1,597 | -1,469 | -1,015 | -188.65 | -13.78 | -24.7 |
Interest & Investment Income | 53.4 | 76.9 | 184.14 | 336.08 | 732.91 | 223.72 |
Earnings From Equity Investments | -2.12 | -2.12 | - | - | - | - |
Currency Exchange Gain (Loss) | 4.74 | -4.95 | 19.9 | -82.46 | 95.15 | 123.06 |
Other Non Operating Income (Expenses) | -577.36 | -1,264 | -88.01 | -519.78 | -196.06 | -92.79 |
EBT Excluding Unusual Items | -18,399 | -21,264 | -25,170 | -15,875 | 1,515 | 11,653 |
Gain (Loss) on Sale of Investments | -18.72 | -4.04 | -85.98 | 125.03 | -0.06 | -2.84 |
Gain (Loss) on Sale of Assets | 212.76 | 389.84 | 364 | 9.84 | -2.8 | -12.09 |
Pretax Income | -18,205 | -20,878 | -24,892 | -15,740 | 1,512 | 11,638 |
Income Tax Expense | 2,325 | 2,325 | 1,338 | -4,131 | 194.37 | 355.96 |
Earnings From Continuing Operations | -20,530 | -23,203 | -26,230 | -11,609 | 1,318 | 11,282 |
Minority Interest in Earnings | 396.71 | 745.96 | 942.32 | 533 | 1,923 | - |
Net Income | -20,133 | -22,457 | -25,288 | -11,076 | 3,241 | 11,282 |
Net Income to Common | -20,133 | -22,457 | -25,288 | -11,076 | 3,241 | 11,282 |
Net Income Growth | - | - | - | - | -71.28% | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 5 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 5 |
Shares Change | -0.01% | -0.03% | 0.03% | - | 15.58% | - |
EPS (Basic) | -3556.24 | -3966.29 | -4465.00 | -1956.24 | 572.33 | 2303.11 |
EPS (Diluted) | -3556.24 | -3966.29 | -4465.00 | -1956.24 | 570.00 | 2303.11 |
EPS Growth | - | - | - | - | -75.25% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8,471 | -11,176 | -15,593 | -37,501 | -15,613 | -9,956 |
Free Cash Flow Per Share | -1496.24 | -1973.85 | -2753.24 | -6623.29 | -2757.44 | -2032.34 |
Gross Margin | 62.96% | 57.58% | 55.29% | 68.87% | 69.78% | 75.58% |
Operating Margin | -22.73% | -25.78% | -36.13% | -23.11% | 0.90% | 8.46% |
Profit Margin | -28.10% | -31.12% | -37.64% | -16.60% | 3.26% | 8.35% |
Free Cash Flow Margin | -11.82% | -15.49% | -23.21% | -56.20% | -15.72% | -7.37% |
EBITDA | -14,348 | -16,602 | -21,976 | -13,775 | 2,039 | 12,496 |
EBITDA Margin | -20.03% | -23.01% | -32.71% | -20.64% | 2.05% | 9.25% |
D&A For EBITDA | 1,933 | 2,000 | 2,295 | 1,645 | 1,142 | 1,072 |
EBIT | -16,280 | -18,601 | -24,271 | -15,420 | 897.02 | 11,424 |
EBIT Margin | -22.73% | -25.78% | -36.13% | -23.11% | 0.90% | 8.46% |
Effective Tax Rate | - | - | - | - | 12.85% | 3.06% |
Advertising Expenses | - | 18,442 | 17,861 | 17,997 | 23,875 | 29,357 |